These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1005 related items for PubMed ID: 22972135

  • 1. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD009159. PubMed ID: 22972135
    [Abstract] [Full Text] [Related]

  • 2. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Chakupurakal G, Freudenberger P, Skoetz N, Ahr H, Theurich S.
    Cochrane Database Syst Rev; 2023 Jun 21; 6(6):CD009159. PubMed ID: 37341189
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.
    Cochrane Database Syst Rev; 2014 Apr 20; 2014(4):CD010189. PubMed ID: 24748537
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J.
    Cochrane Database Syst Rev; 2019 Jan 30; 1(1):CD009768. PubMed ID: 30697701
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation.
    Quellmann S, Schwarzer G, Hübel K, Greb A, Engert A, Bohlius J.
    Cochrane Database Syst Rev; 2008 Jul 16; (3):CD004885. PubMed ID: 18646116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F, Bartel C, Grouven U.
    Cochrane Database Syst Rev; 2013 Jul 23; 2013(7):CD006407. PubMed ID: 23881658
    [Abstract] [Full Text] [Related]

  • 10. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS, Lee MS, Min CW, Park SK, Kim SH, Yun J, Kim HJ, Kim KH, Kim CK, Lee KT, Won JH, Hong DS.
    Korean J Intern Med; 2016 Jul 23; 31(4):750-61. PubMed ID: 27017944
    [Abstract] [Full Text] [Related]

  • 11. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM, Kornblit B, Storer BE, Olesen G, Maris MB, Langston AA, Gutman JA, Petersen SL, Chauncey TR, Bethge WA, Pulsipher MA, Woolfrey AE, Mielcarek M, Martin PJ, Appelbaum FR, Flowers MED, Maloney DG, Storb R.
    Lancet Haematol; 2019 Aug 23; 6(8):e409-e418. PubMed ID: 31248843
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis.
    Luo C, Huang X, Wu G, Huang Y, Ding Y, Huang Z, Song Q, Chen J, Li X, Xu S.
    Transplant Cell Ther; 2024 Jul 29. PubMed ID: 39084262
    [Abstract] [Full Text] [Related]

  • 14. Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.
    Kumar A, Mhaskar AR, Reljic T, Mhaskar RS, Kharfan-Dabaja MA, Anasetti C, Mohty M, Djulbegovic B.
    Leukemia; 2012 Apr 29; 26(4):582-8. PubMed ID: 22182922
    [Abstract] [Full Text] [Related]

  • 15. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW.
    Biol Blood Marrow Transplant; 2017 Sep 29; 23(9):1498-1508. PubMed ID: 28554856
    [Abstract] [Full Text] [Related]

  • 16. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A, Mallick R, Huebsch L, Allan D, Atkins H, Anstee G, Sabloff M, Scrivens N, Maze D, Bredeson C, Kekre N.
    Biol Blood Marrow Transplant; 2017 Dec 29; 23(12):2096-2101. PubMed ID: 28821454
    [Abstract] [Full Text] [Related]

  • 17. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients.
    Kim BK, Hong KT, Choi JY, Kim H, Park HJ, Kang HJ.
    Ann Hematol; 2024 Jun 29; 103(6):2051-2058. PubMed ID: 38594416
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.